Hemodilution causes glycocalyx shedding without affecting vascular endothelial barrier permeability in rats by Ergin, Bülent et al.








Hemodilution causes glycocalyx shedding without affecting vascular
endothelial barrier permeability in rats
Ergin, Bülent ; Guerci, Philippe ; Uz, Zühre ; Westphal, Martin ; Ince, Yasin ; Hilty, Matthias ; Ince,
Can
Abstract: Background The consequences of acute normovolemic hemodilution (ANH) following different
types of fluids on the different components of the glycocalyx and on vascular barrier permeability (VBP)
remain unknown. Aim The aim of the study was to investigate whether the microcirculatory disruption
and glycocalyx shedding induced by ANH alters VBP and whether this is affected by the composition
and volume of the resuscitation fluid. Materials and Methods Anesthetized Wistar albino rats (n=24)
underwent stepwise ANH at hematocrit levels of 35%, 25%, 20%, and 15% induced by the exchange of
blood with 6% balanced hydroxyethyl starch (1:1), balanced crystalloid (1:3), and normal saline (NS)
(1:3). Glycocalyx-shed products were measured at each level of hemodilution. VBP was reflected in
the decay of fluorescence dyes of different molecular size and their plasma retention ratios. Edema was
assessed by measuring organ water content and muscle microcirculation by hand-held videomicroscopy.
Results NS caused increased degradation of heparan sulfate and hyaluronan compared with the control
group (P=0.003, P=0.004, respectively). Neither VBP nor tissue edema was affected by the fluid used.
The total and perfused vessel densities within the microcirculation of muscle tissue decreased at hemat-
ocrit 15% in the balanced crystalloid (P=0.02) and NS groups only (P<0.0001, P=0.0003, respectively)
compared with baseline. Conclusions Balanced colloid solution preserved the glycocalyx layer better than
balanced and unbalanced crystalloid solutions while maintaining the microcirculatory function associated
with an improved total intravascular volume. Among the fluids tested, NS caused the most microcircu-
latory alterations. While ANH caused the degradation of glycocalyx components regardless of fluid, it
did not disrupt the vascular barrier as indicated by macromolecular leakage. Relevance for Patients The
results of this study provide insight into the choice of fluid for optimal perioperative fluid management
and the consequences of fluid type on the vascular barrier, glycocalyx, and microcirculation.
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ABSTRACT
Background: The consequences of acute normovolemic hemodilution (ANH) following different 
types of fluids on the different components of the glycocalyx and on vascular barrier permeability 
(VBP) remain unknown.
Aim: The aim of the study was to investigate whether the microcirculatory disruption and glycocalyx 
shedding induced by ANH alters VBP and whether this is affected by the composition and volume of 
the resuscitation fluid.
Materials and Methods: Anesthetized Wistar albino rats (n=24) underwent stepwise ANH at 
hematocrit levels of 35%, 25%, 20%, and 15% induced by the exchange of blood with 6% balanced 
hydroxyethyl starch (1:1), balanced crystalloid (1:3), and normal saline (NS) (1:3). Glycocalyx-shed 
products were measured at each level of hemodilution. VBP was reflected in the decay of fluorescence 
dyes of different molecular size and their plasma retention ratios. Edema was assessed by measuring 
organ water content and muscle microcirculation by hand-held videomicroscopy.
Results: NS caused increased degradation of heparan sulfate and hyaluronan compared with the 
control group (P=0.003, P=0.004, respectively). Neither VBP nor tissue edema was affected by 
the fluid used. The total and perfused vessel densities within the microcirculation of muscle tissue 
decreased at hematocrit 15% in the balanced crystalloid (P=0.02) and NS groups only (P<0.0001, 
P=0.0003, respectively) compared with baseline.
Conclusions: Balanced colloid solution preserved the glycocalyx layer better than balanced and 
unbalanced crystalloid solutions while maintaining the microcirculatory function associated with an 
improved total intravascular volume. Among the fluids tested, NS caused the most microcirculatory 
alterations. While ANH caused the degradation of glycocalyx components regardless of fluid, it did 
not disrupt the vascular barrier as indicated by macromolecular leakage. 
Relevance for Patients: The results of this study provide insight into the choice of fluid for optimal 
perioperative fluid management and the consequences of fluid type on the vascular barrier, glycocalyx, 
and microcirculation.
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1. Introduction
The optimal choice for perioperative fluid administration 
has been a source of debate for the past 40 years [1,2]. In the 
perioperative setting, acute normovolemic hemodilution (ANH) 
is required to compensate for blood loss or hypovolemia [3,4]. 
However, it is well-known that the composition and volume of 
the fluids being administered affect the endothelial cells, tissues, 
and organs potentially leading to coagulopathy, edema, hypoxia, 
endothelial damage, and acidosis. 
The glycocalyx is an endothelial cell lining composed of highly 
negatively charged glycosaminoglycans that provide a protective 
layer and regulates leukocyte to endothelial cell adhesion and 
direct macromolecular trafficking. In a human clinical setting, 
ANH does not affect the glycocalyx constituents, in contrast to 
hypervolemia, due to the action of atrial natriuretic peptides [5]. 
The disruption of the glycocalyx is the primary cause of increased 
vascular barrier permeability (VBP), which leads to secondary 
tissue edema and other unfavorable outcomes [6]. However, 
considering that VBP tightly regulated, the importance of the 
contribution of the glycocalyx to VBP has been questioned 
recently in relation to the other constitutive elements [7].
Different types of fluid used for increasing blood volume or 
compensating for intraoperative blood loss (leading to ANH) 
impact the glycocalyx in different ways. Colloid solutions 
preserve glycocalyx components by maintaining the shear stress 
on the endothelium with its higher viscosity [8] and osmotic 
pressure. However, the degree to which glycocalyx shedding is 
affected by stepwise ANH with different types of fluid has not 
been investigated. In addition, the effect of ANH on VBP has not 
yet been described.
The aims of the present study are: (i) To investigate which of 
the different components of the glycocalyx are shed in response 
to the fluids commonly used perioperatively, and (ii) to test the 
impact of glycocalyx degradation on microcirculatory parameters 
and VBP in stepwise ANH.
2. Materials and Methods
2.1. Animals
This study was approved by the Animal Research Committee 
of the Amsterdam University Medical Center (DFL 190AA). All 
procedures were performed in accordance with the guidelines of the 
Institutional Animal Care and Use Committee and the Declaration 
of Helsinki. Data are reported in line with the ARRIVE guidelines 
for reporting in vivo experiments. Experiments were performed 
in the Department of Translational Physiology (Amsterdam 
University Medical Center, Amsterdam, the Netherlands) on male 
Wistar albino rats (Charles River Laboratories, the Netherlands), 
aged 10±3 weeks, with a mean±SD bodyweight of 309±17 g. 
2.2. Surgical preparation
Anesthesia was induced with an intraperitoneal injection 
of 100 mg/kg ketamine (Nimatek; Eurovet, the Netherlands), 
0.5 mg/kg dexmedetomidine (Dexdomitor; Pfizer, NY, USA), and 
0.05 mg/kg atropine-sulfate (Centrafarm, the Netherlands) and 
sustained with continuous intravenous infusion of 50 mg/kg/h 
ketamine. Fluid levels were maintained with Ringer’s acetate 
solution (Baxter, Utrecht, the Netherlands) at a rate of 10 ml/kg/h. 
After the tracheostomy, the animals were connected to a ventilator 
(Babylog 8000, Dräger, the Netherlands) set to tidal volumes of 
6 ml/kg and a positive end-expiratory pressure of 3 cmH2O and 
FiO2 of 0.4. A heating pad was used to maintain the animals’ body 
temperatures at 37±0.5°C. End-tidal CO2 was kept between 30 
and 35 mmHg (CapnoMac, Datex-Ohmeda, USA) by adjusting 
ventilator settings. A detailed description of the surgical procedure 
is available in the literature [7].
2.3. Experimental protocol
Animals (n=6/group) were randomized according to a unique 
code generated by an internet website (http://www.sealedenvelope.
com). On the 1st day of the experiment, a technician prepared the 
fluid used for the hemodilution protocol according to the generated 
code. After a 30-min stabilization period, baseline hemodynamic 
values, including mean arterial pressure (MAP), were recorded, 
and arterial blood gas levels were assessed (ABLFlex 80, 
Radiometer, Denmark).
ANH was induced in three groups by the stepwise exchange 
of blood (withdrawn at a rate of 0.5 ml/min) using a syringe 
pump (Harvard Apparatus, USA) and exchanged with one of the 
following plasma expanders according to the following ratios: 1:1 
for 6% balanced hydroxyethyl starch (HES) (Volulyte 6% HES 
130/0.4 in Ringer’s acetate), 1:3 for balanced crystalloid (Ringer’s 
acetate), and 1:3 for normal saline (NS) 0.9% until successive target 
levels of hematocrit were reached, approximately 45 min each. 
All solutions were purchased from Fresenius Kabi (Germany). A 
fourth group was instrumentally prepared but received no fluid 
and served as a time control group. Each stepwise hemodilution 
targeted four hematocrit levels: 35%, 25%, 20%, and 15%. The 
time course of the experiment is presented in Figure 1.
2.4. Biomarkers of glycocalyx shedding
Circulating plasma syndecan-1, heparan sulfate, and hyaluronan 
were measured as surrogates for glycocalyx. The stored plasma 
samples were thawed and analyzed using commercial enzyme-
linked immunosorbent assay (ELISA) kits according to the 
manufacturer’s instructions: DuoSet Hyaluronan (DY3614, R&D 
Systems, Minneapolis, MN, USA), Syndecan-1/CD138(SCD1) 
ELISA Kit (Cusabio Biotech, Wuhan, China), and Heparan 
Sulfate Proteoglycan 2 (HSPG2) ELISA Kit (Cusabio Biotech) 
were used for this purpose.
2.5. Skeletal microcirculatory measurements
A hand-held vital microscope with incident dark-field (IDF) 
imaging, CytoCam (Braedius Scientific, Huizen, the Netherlands) 
was placed on the surface of the exposed biceps femoris to 
continuously monitor the microcirculation. One hundred frame clips 
(100 s) were recorded at every time point for each hematocrit level. 
All clips were randomly anonymized, and the microcirculation 
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was analyzed blindly (group and time point) at baseline and each 
hemodilution time point using Automated Vascular Analysis 3.2 
(Microvision Medical, Amsterdam, the Netherlands). Recorded 
parameters included total vessel density (TVD), perfused vessel 
density (PVD), the proportion of perfused vessels (PPV), and 
mean flow index (MFI), as previously described [9,10].
2.6. Assessment of VBP and tissue edema
2.6.1. Fluorescent tracers
A fluorescence-based VBP analysis was performed as 
previously described [7]. Fluid maintenance was halted at 
the end of the experiment. Three fluorescent dyes conjugated 
with different sized molecules and dissolved in saline were 
thoroughly mixed and manually injected intravenously over 1 
min: Texas-Red-40 kDa dextran (10 mg/ml, D1829, Thermo 
Fischer Scientific, Breda, the Netherlands), albumin-Alexa 680 
(albumin 70 kDa) (5 mg/ml, A34787, Thermo Fischer Scientific, 
Breda, the Netherlands), and fluorescein isothiocyanate (FITC)-
500 kDa dextran (10 mg/ml, MFCD00131092, Sigma-Aldrich, 
Zwijndrecht, the Netherlands) (100 µl each). The blood samples 
(200 µl) were withdrawn at 2, 5, 10, 15, 20, 25, and 30 min 
to measure the decay in plasma concentration of the dyes, as 
described in detail in the literature [7]. Plasma concentrations 
were determined for each dye using a 96-well plate fluorometer 
(ClarioStar, BMG LabTech, Ortenberg, Germany) in accordance 
with the excitation/emission wavelengths of each dye and a 
standard calibration curve. Measured wavelengths included 
580±20 nm/625±20 nm for FITC, 480±15 nm/530±25 nm for 
Texas-Red, and 675±10 nm/740±40 nm for Alexa 680. The 
retention ratio (RR) of each dye was calculated as follows: 
RR=final concentration at 30 min/initial concentration at 2 
min. For total intravascular volume (TIV) and plasma volume 
(PV) determinations, the concentration of albumin-Alexa 680 
was determined 2 min after the bolus injection according to the 
following equation:










Hematocrit is expressed as percentage (e.g., 15%=0.15). “0.1” 
corresponds to the volume (in ml) of albumin Alexa 680 contained 
injected from the syringe.
2.6.2. Tissue edema
At the end of the experiments, organs (heart, brain, kidney, 
lung, and liver) were harvested to determine their water content. 
The organs were placed in an oven at 100°C for 24 h. The wet-to-
dry weight ratio was calculated as follows: Wet tissue weight/dry 
tissue weight.
2.7. Statistical analysis
nQuery Advisor was used to determine that, for a sample size of 
six per group, 80% power is required to detect a MAP difference 
of 46 mmHg between the control and hemodiluted groups with 
an average standard deviation (SD) of 25 using a two-group t-test 
with α=0.05 two-sided significance level.
Values are expressed as mean±SD when normally distributed 
(Kolmogorov–Smirnov test) or as median (interquartile range) 
when not. Ninety-five percent confidence intervals (95% CI) 
are reported when necessary. Repeated measures two-way 
analysis of variance (RM-ANOVA) (two factors: Time as the 
related within-animal factor and group as the between-animal 
factor) with Bonferroni’s post hoc multiple comparisons test 
were used to determine inter- and/or intra-group differences in 
hemodynamic, microcirculatory, biochemical, and glycocalyx 
degradation biomarkers. When a significant interaction was 
observed between time points and groups, the main effect of 
group (fluid type) compared with the control and balanced 
HES groups at each time point was reported. The simple main 
effect of time versus baseline within the same group was also 
reported. One-way ANOVA with Bonferroni’s correction was 
used for the RRs. Because of their non-Gaussian distribution, 
the Kruskal–Wallis test was used with Dunn’s post-test. The 
fluorescence values from each time point were fitted with an 
exponential one-phase decay curve using the least-squares 
method. Statistical analysis was performed using GraphPad 
Prism version 8.1.2 for Mac (GraphPad Software, La Jolla, 
CA, USA).
For comparison of microcirculatory parameters relative to 
baseline and hemodilution time points, two-way linear mixed-
effects model analysis was used (R, using the R library lme4, 
version 1.1.13). Subgroups for which a statistically significant 
effect was detected were further analyzed using a one-way linear 
mixed-effects model. The overall significance level used for each 
hypothesis was 0.05. Adjusted P-values were reported throughout 
the manuscript for the post hoc tests. No a priori power analysis was 
performed.
Figure 1. Time course of the acute normovolemic hemodilution.
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3. Results
3.1. Systemic hemodynamics and blood variables
All rats (n=24) survived the stepwise ANH procedure. 
However, ANH was associated with a significant decrease in MAP 
in all groups compared with control, which peaked at hematocrit 
15% (F [4, 20]=113.7, P<0.0001). The hemodynamic data are 
summarized in Table 1. 
Stepwise ANH with 0.9% saline induced progressive metabolic 
acidosis (F [3, 15]=16.89, P<0.0001) accompanied by changes 
in pH and bicarbonate levels relative to control (7.29±0.05 
vs.7.41±0.02, mean diff. 0.12, 95% CI [0.09; 0.15], P<0.0001) 
(Table 1). At a hematocrit level of 15%, ANH was significantly 
associated with hyperlactatemia regardless of the fluid administered 
(2.7±1 mmol/l, mean diff. −1.27, 95% CI [−1.81; −0.72] for 
balanced colloid, 2.4±0.7 mmol/l, mean diff. −0.95, 95% CI 
Table 1. Hemodynamics, blood hematocrit, hemoglobin, lactate, and arterial partial pressure of CO2 levels throughout experiment
Baseline Hct 30% Hct 25% Hct 20% Hct 15%
MAP (mmHg)
Control 92±14 80±4 80±11 80±10 84±10
Balanced HES 95±10 66±1* 60±1* 58±4* 56±5*
Balanced crystalloid 87±10 66±11* 54±4* 54±8* 47±7*
NaCl % 0.9 90±12 61±5* 56±5* 50±2* 42±5*
CVP (mmHg)
Control 7±1 7±1 6±2 6.5±1.5 7±1
Balanced HES 6±1 6±1 7±1 6.9±1.3 7±1
Balanced crystalloid 6±1 7±1 7±2 7±2 7±2
NaCl % 0.9 5±1* 5±1* 6±1# 6±1# 6±1*#
Hemoglobin (g/dl)
Control 14.2±0.5 13.5±1.1 12.9±1 13.6±1.1 12.2±1.3
Balanced HES 14.6±0.8 9.6±0.5* 7.9±0.7* 6.2±0.4* 4.6±0.4*
Balanced crystalloid 14.9±0.8 9.9±0.9* 7.8±0.6* 6.2±0.3* 4.7±0.4*
NaCl % 0.9 14.3±1.4 10.1±0.3* 8±0.4* 6.5±0.5* 4.8±0.2*
Hematocrit (%)
Control 44±1 41±3 40±3 41±4 37±4
Balanced HES 45±2 30±2* 25±1* 20±1* 15±2*
Balanced crystalloid 46±3 31±2* 25±2* 20±1* 15±1*
NaCl % 0.9 45±4 31±1* 25±1* 21±1* 15±1*
pH
Control 7.42±0.05 7.40±0.02 7.42±0.03 7.42±0.02 7.41±0.02
Balanced HES 7.45±0.03 7.44±0.03 7.44±0.04 7.40±0.03 7.39±0.03
Balanced crystalloid 7.44±0.03 7.41±0.02 7.40±0.02 7.40±0.02 7.36±0.02*




Control 21.3±1.7 20.1±2 18.9±0.8 19.2±1.4 20.4±1.2
Balanced HES 20.9±1.2 23.1±1.2* 24±1* 23.5±1.5* 23±1.6*
Balanced crystalloid 20.8±2.2 22±2.1* 22.7±1.5* 21.9±1.7* 22.7±1.8*
NaCl % 0.9 20.4±2.4 19.8±1.5+# 19.1±1.5+# 18.4±1.5+# 16.8±1.5*+#
Lactate (mmol/L)
Control 0.9±0.3 1.2±0.3 1.2±0.6 1.5±0.5 1.5±0.5
Balanced HES 0.9±0.2 1.1±0.3 1.3±0.5 2.1±0.8* 2.7±1*
Balanced crystalloid 1.3±0.3 1.4±0.6 1.9±0.7* 2.4±0.7* 2.4±0.7*
NaCl % 0.9 1.1±0.2 1.1±0.7 1.4±0.3* 1.6±0.4# 2.5±0.5*
PaCO2 (mmHg)
Control 34±5 33±4 30±1 30±1 33±3
Balanced HES 31±3 35±4 36±4* 39±3* 39±2*
Balanced crystalloid 31±3 36±5 37±3* 36±3* 41±3*
NaCl % 0.9 30±3 35±3 36±4* 38±5* 36±3#
Hct: Hematocrit, MAP: Mean arterial pressure, HCO
3
−: Bicarbonate, CVP: Central venous pressure, HES: Hydroxyethyl starch. Data are presented as mean±SD. *Adjusted P<0.05 versus control 
group, # adjusted P value versus balanced HES group 
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[−1.49; −0.41] for balanced crystalloid, and 2.5±0.5 mmol/l, mean 
diff. −0.85, 95% CI [−1.39; −0.31] for NS, P<0.001) compared 
with control (1.5±0.5 mmol/l). The total volume of balanced HES 
required during the experiment to achieve each step of ANH was 
significantly lower (10.8±0.9 ml) than in the balanced crystalloid 
(27.5±2.8 ml) and NS (29±2.2 ml) groups (P=0.0001) (Figure 2).
Urine output decreased with hematocrit level in all groups 
compared with baseline (F [4, 20]=15.35, P<0.0001) (Figure 3). 
However, at a hematocrit level of 15%, only ANH with 0.9% saline 
group exhibited significantly decreased urine output compared 
with the control group (0.001±0.001 vs. 0.01±0.002 ml/g BW−1, 
mean diff. 0.008, 95% CI [−0.001; 0.017], P=0.03). 
3.2. Plasma and TIV 
PV increased in all groups compared with control (F [3, 
20]=35.68, P<0.0001) (Figure 4A). However, TIV (Figure 4B) 
only increased in the balanced HES group (18.8±1.1 ml) compared 
with control (17.2±1.2 ml) (mean diff. −1.6, 95% CI [−3.1; −0.07], 
P=0.039). Despite similar hematocrit levels in all ANH groups 
(Table 1), only hemodilution with balanced HES increased the 
intravascular volume. 
3.3. Glycocalyx degradation biomarkers
Syndecan-1 was shed throughout the experiment in all groups 
including control. At the end of experiment (hematocrit 15%), 
syndecan-1 levels were significantly higher than baseline (F [3, 
60]=23.88, P<0.0001) (Figure 5A). ANH with NS resulted in 
significant shedding of heparan sulfate (Figure 5B) and hyaluronan 
(Figure 5C) compared with control (mean diff. −1213, 95% CI 
[−2070; −356], P=0.003 and −66, 95% CI [−115; −18], P=0.004, 
respectively). Similarly, balanced crystalloid solution altered the 
hyaluronan (mean diff. −59, 95% CI [−107.6; −10.33], P=0.013) 
but not heparan sulfate levels. ANH using balanced HES only 
induced minimal changes to the levels of the components shed 
from the glycocalyx.
3.4. VBP
3.4.1. Fluorescent tracers in the vascular compartment
The RRs of the fluorescent dyes injected into the vascular 
system after the last ANH time point are shown in Figure 6. 
Thirty minutes post-injection, the smallest fluorescent dye (Texas-
Red 40 kDa) was significantly retained within the vasculature 
independent of the fluid administered (F [3, 19]=7.529, P=0.0016). 
The balanced HES group showed the highest Texas-Red 40 kDa 
RR compared with the control group (0.61±0.08 vs. 0.41±0.06 
mean diff. −0.2, 95% CI [−0.32; −0.08], P=0.0012). These results 
indicate an absence of increased vascular leakage in ANH. 
Figure 7 shows the decays curves associated with each fluid 
group according to each fluorescent tracer. Compared with 
RRs, the powers of the exponential decay curves only tended 
to be different between fluids and control groups with regard 
to the Texas-Red 40 kDa dye but did not reach statistical 
significance.
3.4.2. Tissue edema
The water content of each organ using the wet-to-dry weight 
ratio method is summarized in Figure 8. Except in the liver, no 
significant tissue edema was present post-ANH regardless of the 
type of fluid administered. 
3.5. Microcirculation of the muscle during stepwise ANH
Figure 9 depicts the microcirculatory changes occurring during 
ANH according to the type of fluid used. Baseline values within 
each group, ANH altered both TVD and PVD. ANH with balanced 
colloid altered the microcirculatory parameters a lesser degree 
of especially with regards to PVD. The maximum decrease in 
TVD and PVD were observed at a hematocrit level of 15% in the 
crystalloid groups, with mean differences of 3.1, 95% CI (0.32; 
5.9), P=0.02 and 4.7, 95% CI (1.9; 7.5), P=0.0003 for balanced 
Figure 2. Total fluid volumes during acute normovolemic hemodilution. 
Ordinary One-way ANOVA test with Bonferroni’s correction to adjust 
for multiple comparisons. *adjusted P<0.0001 versus Control group 
(n=6/group).
Figure 3. Urine output during acute normovolemic hemodilution. 
Repeated measures two-way ANOVA test used with Bonferroni’s 
correction to adjust for multiple comparisons. *adjusted P<0.01 versus 
control group at the same time point (n=6/group).
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crystalloid and NS groups, respectively, compared with baseline. 
No changes were detected in MFI or PPV compared with baseline.
Two-way linear mixed effects model analysis was used. $ 
P<0.05 compared to baseline within the same group (n=6/group).
4. Discussion
In this translational study, ANH with balanced HES prevented 
the shedding of different components of the glycocalyx. 
Figure 5. Plasma levels of syndecan-1 (panel A), heparan sulfate (panel B), and hyaluronan (panel C) during experiments. Increased glycocalyx 
shedding persists after fluid administration except for the hyaluronan component, which decreases when balanced HES is used. RM-ANOVA test 
used with Bonferroni’s correction to adjust for multiple comparisons. *adjusted P<0.01 versus control group at the same time point, # P<0.05 versus 
balanced HES group, $ P<0.05 versus baseline value within the same group (n=6/group).
CBA
Figure 6. Retention ratios of fluorescent dyes at the end experiments. Ordinary one-way ANOVA test with Bonferroni’s correction to adjust for 
multiple comparisons. *adjusted P<0.05 versus control group (n=6/group).
CBA
Figure 4. Plasma and total intravascular volumes at the end of experiments determined by measurement of albumin Alexa. Ordinary one-way ANOVA 
test with Bonferroni’s correction to adjust for multiple comparisons. *adjusted P<0.001 versus control group (n=6/group).
BA
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Figure 8. Edema in different organs assessed by the wet to dry weight ratio *adjusted P<0.05 versus control group (n=6/group).
Figure 9. Microcirculatory muscle alterations at each step of acute normovolemic hemodilution. Total vessel density (Panel A), perfused vessel density 
(Panel B), proportion of perfused vessels (Panel C), and mean Flow Index (Panel D) are presented.
DC
BA
Figure 7. (A-C) Decay traces of each fluid group classified by fluorescent tracer.
A B C
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However, crystalloids, either balanced or not, significantly shed 
glycocalyx components, namely, syndecan-1 and hyaluronan, in 
comparison to balanced HES. Only ANH with NS resulted in 
the degradation of all three main constituents of the glycocalyx. 
However, despite glycocalyx degradation following maximum 
ANH, no increase in VBP was observed, regardless of fluid 
type and composition. While ANH at a hematocrit level of 15% 
induced microcirculatory disturbances, which was associated 
with impaired macrohemodynamics, these were partially 
prevented by the use of balanced HES solution compared with 
crystalloids.
These results are consistent with the previous studies showing 
that low plasma and blood viscosity may dampen the endothelial 
cell response to shear stress and subsequently alter the vascular 
tone [11,12]. Guerci et al. demonstrate that plasma and blood 
viscosity were similarly impacted following resuscitation after 
non-traumatic hemorrhagic shock with either low-(Ringer’s 
lactate) or high-viscosity (HES) plasma expanders [13]. The 
glycocalyx participates in endothelial shear stress-induced 
reactivity by sensing the flow and mediating mechanotransduction 
signals, mainly through syndecan-1 [12,14]. In the present study, 
syndecan-1 was the most shed component following the use of NS. 
Moreover, macrohemodynamics were severely impaired at the 
final stage of ANH with a MAP of 42±4 mmHg in the NS group. 
In the present study, extreme ANH-induced microcirculatory 
disturbances were associated with hypotension, endothelial 
glycocalyx degradation, and vascular hyporesponsiveness, as 
previously reported [11], but did not alter the VBP.
The absence of increased VBP following ANH suggests that a 
component of the vascular barrier, such as intercellular junctions, 
can withstand the transendothelial water flux despite partial 
glycocalyx degradation [15]. Thus, the typical transendothelial 
flux of proteins and water in and out of the interstitial space can 
be maintained during ANH. Moreover, in agreement with our 
findings, Rehm et al. found that, in addition to the glycocalyx, 
another component of the vascular endothelial barrier formed by 
endothelial cells (“double-barrier” concept) may play a role in 
fluid maintenance and colloid extravasation in an isolated heart 
model [16]. In the present study, we showed that small molecules 
(Texas-Red dextran-40 kDa) did not escape more rapidly 
from the vascular compartment than larger ones, as suggested 
by the similar exponential decay curves fitted to the plasma 
concentrations of the dyes, regardless of the fluid used for ANH. 
In addition, the RRs in all ANH groups were higher than the 
control group, which confirms the absence of vascular barrier 
disruption during ANH. Compared with the diluted group, the 
low RR of 40 kDa molecules in the control group indicated more 
leakage of small molecules from the vascular to the interstitial 
space under baseline conditions. The viscosity and shear stress 
created by the red blood cells under baseline conditions could 
contribute to the permeability of the vascular barrier to provide 
osmotic balance in intra- and extra-vascular spaces. However, 
blood viscosity and shear stress reduced by the removal of 
red blood cells may also decrease the permeability of small 
molecules through the vascular barrier to maintain intravascular 
volume. One would expect a decrease in RRs for small molecules 
due to the increased VBP of water and proteins. These results 
imply that, regardless of the type of fluid administered, water 
will relentlessly escape from the vasculature either by urine 
production or by transendothelial outflux. For acute kidney 
injury, the latter is more likely to occur. However, in the present 
study, no fluid accumulation with the wet-to-dry weight ratio 
technique was evidenced in various organs except in the liver 
despite having given 3 times higher volume of crystalloids than 
colloids to achieve the same PV between groups. Due to reduced 
urinary discharge, this extra volume of crystalloids, especially 
saline, might accumulate in the third space. 
The shedding of the glycocalyx has been reported in human 
clinical settings and in preclinical models, as a response to 
ischemia/reperfusion injury [17], trauma [18,19], sepsis [20], 
and even during hyperglycemia [21] and after smoking [22]. In 
a clinical intraoperative setting, Chappell et al. compared the 
effects of volume loading (top-loading) and ANH on the presence 
of glycocalyx shed products in blood plasma using HES 130/0.4 
during elective surgery in patients with healthy heart function [5]. 
In contrast to ANH, volume loading induced a significant release 
of atrial natriuretic peptide that was associated with increased 
plasma hyaluronan and syndecan-1 levels. These findings are 
partially consistent with our results. Although PVs were markedly 
increased secondary to ANH in all groups compared with the 
control group, the TIV only increased in the balanced HES group. 
Finally, balanced HES was less likely than crystalloids to induce 
the shedding of heparan sulfate, hyaluronan, and syndecan-1 
despite the increase in PV, which renders it more suitable for 
maintaining the integrity of the glycocalyx during ANH.
At present, ANH remains well-recognized as a safe procedure 
for perioperative patient management [3,4]. Unintended ANH may 
also result from intraoperative fluid administration. Increasingly 
more patients develop anemia during the post-operative course, 
secondary to unintentional ANH, in response to restrictive red 
blood cell transfusion with no apparent negative outcome [23,24]. 
Even if ANH with NS or balanced crystalloids were to negatively 
impact the glycocalyx, the clinical consequences of this 
degradation remain undetermined.
4.1 Limitations
First, VBP was analyzes using only two assays. Previously, 
we demonstrated similar results in a non-traumatic hemorrhagic 
shock model in rodents using four different techniques [7]. 
Second, we did not investigate glycocalyx ultrastructure by 
electron microscopy or in vivo fluorescent microscopy. We relied 
on surrogates for glycocalyx shedding, which may represent 
a limitation. Third, we did not analyze the consequences of 
hemodilution on microcirculatory oxygen availability in the 
different organs to determine which fluid provides the best 
tissue oxygenation because a similar study has already been 
published [25]. Fourth, due to technical and ethical reasons, we 
did not analyze glycocalyx and endothelial barrier function after 
longer periods of hemodilution.
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5. Conclusions
The use of a balanced colloid solution preserved the 
glycocalyx, maintained microcirculatory function, and improved 
TIV compared with both balanced and unbalanced crystalloids. 
NS had a more deleterious effect than the balanced crystalloid 
and colloid on macro- and micro-circulation during ANH. Despite 
the volumes required to achieve similar ANH in all groups being 
different, no evidence was found of increased VBP or organ 
edema following ANH. Consistent with our previous study in 
non-traumatic hemorrhagic shock, the results of this study suggest 
that glycocalyx shedding may induce the loss of vascular tone in 
response to shear stress without subsequent increment of VBP as 
a result of intercellular vascular barrier disruption. 
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